Gain Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Gain Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Gain Therapeutics Inc
Rating: 1.00191675
Author: Trendlyne DVM scores

about

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncol...

1.70 -0.16 (-8.60%)

46.71% Fall from 52W High

393.0K

XNAS Volume

XNAS 15 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

2.7 / 100

Technically Neutral

37.4 / 100

1Yr Price target upside is 371%

7 analysts

Gain Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Gain Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncol...

46.71% Fall from 52W High

SWOT Analysis

Gain Therapeutics Inc Live Price Chart